Incyte’s eczema cream now approved for pediatric treatment
Incyte Corporation has secured its third U.S. Food and Drug Administration approval for its eczema cream Opzelura, expanding its use for children. The post Incyte’s eczema cream now approved for pediatric treatment appeared first on Delaware Business Times.